ENTRY       D09908                      Drug
NAME        Ganitumab (USAN/INN)
FORMULA     C6472H10028N1728O2020S42
EXACT_MASS  145620.3358
MOL_WEIGHT  145709.9683
SEQUENCE    (Heavy chain)
            QVQLQESGPG LVKPSGTLSL TCAVSGGSIS SSNWWSWVRQ PPGKGLEWIG EIYHSGSTNY
            NPSLKSRVTI SVDKSKNQFS LKLSSVTAAD TAVYYCARWT GRTDAFDIWG QGTMVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            DVVMTQSPLS LPVTPGEPAS ISCRSSQSLL HSNGYNYLDW YLQKPGQSPQ LLIYLGSNRA
            SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCMQGTHWP LTFGQGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H96, H146-H202, H263-H323, H369-H427, H228-H'228, H231-H'231, L23-L93, L139-L199, H222-L219)
  TYPE      Peptide
EFFICACY    Antineoplastic, Insulin-like growth factor 1 receptor antibody
  TYPE      Monoclonal antibody
TARGET      IGF1R (CD221) [HSA:3480] [KO:K05087]
  PATHWAY   hsa04510(3480)  Focal adhesion
            hsa04520(3480)  Adherens junction
            hsa05200(3480)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               INSR family
                IGF1R (CD221)
                 D09908  Ganitumab (USAN/INN)
DBLINKS     CAS: 905703-97-1
            PubChem: 124490615
///
